Provided by Tiger Trade Technology Pte. Ltd.

IQVIA

259.88
+1.000.39%
Post-market: 259.880.00000.00%19:32 EDT
Volume:972.34K
Turnover:253.69M
Market Cap:42.78B
PE:32.19
High:263.51
Open:257.73
Low:257.73
Close:258.88
52wk High:277.40
52wk Low:154.50
Shares:164.60M
Float Shares:151.00M
Volume Ratio:0.74
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):8.07
EPS(LYR):7.84
ROE:22.82%
ROA:5.06%
PB:6.93
PE(LYR):33.15

Loading ...

Centene Corp. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
8 hours ago

Gartner Inc. Stock Climbs 5.2%, Outperforms Peers

Dow Jones
·
Yesterday

Olorofim vs. AmBisome: A Phase III Antifungal Trial With Implications for IQVIA Holdings (IQV)

TIPRANKS
·
Yesterday

IQVIA Launches Explorer for Commercial Decision-Making

MT Newswires Live
·
Oct 08

Iqvia launches Iqvia Explorer

TIPRANKS
·
Oct 08

Iqvia Launches Iqvia Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes

Reuters
·
Oct 08

Mizuho Adjusts Price Target on IQVIA Holdings to $300 From $275

MT Newswires Live
·
Oct 07

Iqvia price target raised to $300 from $275 at Barclays

TIPRANKS
·
Oct 07

Gartner Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Oct 07

Evercore ISI Adjusts Price Target on IQVIA Holdings to $290 From $275, Maintains Outperform Rating

MT Newswires Live
·
Oct 06

IQVIA Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 06

Labcorp Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 03

Gartner Inc. Stock Falls 4.1%, Underperforms Peers

Dow Jones
·
Oct 03

Labcorp Holdings Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Oct 02

Centene Corp. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Oct 02

IQVIA Holdings Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Oct 02

UBS Adjusts IQVIA Price Target to $345 From $240, Maintains Buy Rating

MT Newswires Live
·
Sep 30

IQVIA Holdings Inc. : UBS Raises Target Price to $345 from $240

THOMSON REUTERS
·
Sep 30

Press Release: IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026

Dow Jones
·
Sep 30

IQVIA Sees 'Meaningful' Tailwind From Accelerating New Drug Approvals, RBC Capital Markets Says

MT Newswires Live
·
Sep 30